Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are mentally able to give informed consent to participate, with or without the help of a support person or informant
- People who are willing and able to have blood drawn, complete study-related assessments, and be contacted for follow-up
Who may not be able to join:
- People who are not able to give informed consent, even with a support person or informant present
- People who are unwilling or unable to provide blood samples or complete the required study assessments
- People who are currently taking part in another clinical trial that could affect this study's results
- People with certain existing health conditions, including but not limited to: developmental or degenerative brain conditions, epilepsy, brain infections or inflammation, brain tumours, stroke-related conditions, a significant history of mental illness, a significant head injury that involved loss of consciousness, HIV, syphilis, visual or hearing disabilities, a history of alcohol dependence or substance use disorder, certain autoimmune diseases (such as lupus or rheumatoid arthritis), or cancer (confirm with trial site for the full list)
- People who are currently experiencing delirium, or whose cognitive difficulties appear to be caused by a treatable or reversible condition (such as vitamin B12 deficiency or an underactive thyroid), unless that condition has already been treated and stabilised
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nancy Ip, PhD, Hong Kong University of Science and Technology
Phone: +852-23587304
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Blood biomarker (baseline); Follow up blood biomarker
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.